Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Integration Of Dual GLP-1/GIP Agonist To Enhance Weight-Loss Efficacy In Obesity Treatment Major companies in the GLP-1 receptor agonist market are focusing on the integration of dual GLP-1/GIP agonist therapies designed to deliver greater weight-loss efficacy and broader metabolic benefits compared to traditional single-pathway treatments
doi: 10.1016/j.jmb.2016.06.021 38
Research highlights 1
Among these complications, cognitive dysfunction has emerged as a critical concern, significantly impacting the quality of life and daily activities of individuals with diabetes [3,4]
US$ 23.39
US$ 27.12
US$ 23.05
US$ 26.88
US$ 28.80
US$ 28.10
